FormDSignal
45

ORF Biologics, Inc. raises $2.5M under Reg D

Company raise · Pre-first close · CORALVILLE, IA · Form D filed 2024-12-12
First raise on EDGAR

Why now — by persona

Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.

People on the filing

Steven MichalicekDirector
Jay KamathExecutive Officer, Director
Sara TernesExecutive Officer, Director
Stephen HansonExecutive Officer, Director
Anant KamathExecutive Officer, Director

Signed by Anant Kamath, CEO.

Filing contact

The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.

Other filings by this issuer